Our response to COVID-19

We're supporting people to maintain their wellbeing and manage isolation.


What is tranylcypromine?

Tranylcypromine is a monoamine oxidase inhibitor. It is widely used to treat both depression and anxiety.

What is the evidence for tranylcypromine as a treatment for bipolar disorder?

Low quality evidence is unable to determine the benefits of tranylcypromine for bipolar disorder.

Review authors conclude that additional research is required to establish the efficacy of tranylcypromine as an add on to a mood stabiliser.

April 2019

Last updated at: 4:32 am, 2nd April 2019
To view documentation related to this topic download the files below
Fact Sheet Technical Commentary

NeuRA Libraries

Title Colour Legend:
Green - Topic summary is available.
Orange - Topic summary is being compiled.
Red - Topic summary has no current systematic review available.